Letaplimab represents a novel medical method for addressing complement-mediated diseases. This biologic targets complement component C1q, a critical factor of the complement system, potentially block its early https://safiyankel714460.aboutyoublog.com/51911519/letaplimab-a-new-therapeutic-approach